Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Imagin Medical Inc is engaged in research, development, and commercialization of medical devices in the bio-chemistry industry. The company is developing the i/Blue Imaging System that will establish a new standard of care for urologists and will address the limitations of the current technology in the early detection of bladder cancer through endoscopes. It has completed the development of the Prototype Alpha B, an advanced combination of optical/light sensor technology, white light and near-infrared fluorescence.
Vancouver, BC, V6C 1J9, Canada